A similar study is attempting to investigate the role of concurrent avelumab (PD-L1 inhibitor) combined with radiotherapy (63–66 Gy over 30 fractions) in the treatment of unresectable cSCC [NCT03737721]. Here, CD274 is linked to skin squamous cell carcinoma.